Balanced news tone
News Sentiment
PFE sentiment intelligence
Pfizer Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
35 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-0.8% over one week, -6.3% over four weeks, trend inactive, and near fair-value range.
Pfizer (PFE) Stock Looks Fairly Priced With Pipeline Risks In View
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-0.8%
Price digesting
Trend fit
Trend inactive
-6.3% over four weeks
Fair value
-3.6%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
19
Negative
9
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Pfizer (PFE) Stock Looks Fairly Priced With Pipeline Risks In View
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 16 Jul 2026 17:12
- Source
- Market source
The Globe and Mail
Direct company coverage
Pfizer Stock Below 50-Day and 200-Day SMA: Buy the Dip or Exit Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 16:26
- Source
- The Globe and Mail
Seeking Alpha
Direct company coverage
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 12:09
- Source
- Seeking Alpha
ad-hoc-news.de
Direct company coverage
Pfizer Abrysvo by Pfizer Inc. - RSV vaccine targets seniors and pregnant women
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 06:34
- Source
- ad-hoc-news.de
TechStock²
Direct company coverage
Pfizer (NYSE:PFE) Faces New Patent Claim After $96 Billion in COVID Vaccine Revenue
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 21:47
- Source
- TechStock²
simplywall.st
Direct company coverage
Pfizer (PFE) Stock Looks Fully Priced After Its 21% Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 17:38
- Source
- simplywall.st
Market source
Direct company coverage
Here's What to Expect From Pfizer's Next Earnings Report
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 14:02
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Pfizer Abrysvo by Pfizer Inc. - RSV vaccine targets older adults and pregnancy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 05:10
- Source
- ad-hoc-news.de
Encyclopedia Britannica
Direct company coverage
Pfizer Inc.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 14:38
- Source
- Encyclopedia Britannica
Market source
Direct company coverage
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is Pfizer (PFE) Stock Undervalued Despite Mixed Oncology Progress?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is Pfizer Inc. (PFE) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Business Wire
Direct company coverage
Pfizer Declares Third-Quarter 2026 Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 24 Jun 2026 07:00
- Source
- Business Wire
Market source
Direct company coverage
Pfizer (PFE) Is Down 7.3% After Mixed Oncology Updates Reshape Its Long-Term Pipeline Narrative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Market source
Reuters
Direct company coverage
Pfizer CEO warns German investment at risk over drug pricing policies
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Reuters
ad-hoc-news.de
Direct company coverage
Pfizer Inc stock (US7170811035): focus on oncology pipeline after Jefferies 2026 appearance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Pfizer Inc. stock (US7170811035): shares steady as investors digest oncology deal news and recent ea
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 03 Jun 2026 07:00
- Source
- ad-hoc-news.de
Stock Titan
Direct company coverage
If You Invested $1,000 in Pfizer (PFE)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Mar 2026 02:02
- Source
- Stock Titan
Forbes
Direct company coverage
Is There 25% Downside For Pfizer Stock?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Feb 2026 08:00
- Source
- Forbes
Forbes
Direct company coverage
Pfizer vs. Merck Stock And JNJ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- Forbes
Bloomberg.com
Direct company coverage
Pfizer Forecasts Flat 2026 Sales as It Builds Drug Pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Dec 2025 08:00
- Source
- Bloomberg.com
Market source
Direct company coverage
Pfizer Cuts BioNTech Stake by More Than Half
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 14 Nov 2025 08:00
- Source
- Market source
Reuters
Direct company coverage
Pfizer slashes stake in COVID vaccine partner BioNTech
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 Nov 2025 08:00
- Source
- Reuters
Bloomberg.com
Direct company coverage
Pfizer Looks to Sell Stake in Pandemic Vaccine Partner BioNTech
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 13 Nov 2025 08:00
- Source
- Bloomberg.com